We are live on ! Find out more
AA

AlphaMark Advisors Portfolio holdings

AUM $231M
1-Year Est. Return 19.98%
This Fund
S&P 500
This Quarter Est. Return
+4.85%
1 Year Est. Return
+19.98%
3 Year Est. Return
+26.38%
5 Year Est. Return
+72.27%
10 Year Est. Return
+180.76%
AUM
$217M
AUM Growth
-$5.69M
Cap. Flow
-$14.7M
Cap. Flow %
-6.79%
Top 10 Hldgs %
44.19%
Holding
671
New
37
Increased
83
Reduced
179
Closed
34
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PDBC icon
576
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.38B
$1K ﹤0.01%
39
PFBC icon
577
Preferred Bank
PFBC
$1.24B
$1K ﹤0.01%
17
RMAX icon
578
RE/MAX Holdings
RMAX
$193M
$1K ﹤0.01%
77
ROKU icon
579
Roku
ROKU
$21.5B
$1K ﹤0.01%
21
+19
+950% +$1.15K
ROP icon
580
Roper Technologies
ROP
$38.8B
$1K ﹤0.01%
3
SHYD icon
581
VanEck Short High Yield Muni ETF
SHYD
$451M
$1K ﹤0.01%
25
SLRC icon
582
SLR Investment Corp
SLRC
$686M
$1K ﹤0.01%
+50
New +$716
SSTK icon
583
Shutterstock
SSTK
$198M
$1K ﹤0.01%
12
TNDM icon
584
Tandem Diabetes Care
TNDM
$1.34B
$1K ﹤0.01%
30
VTWO icon
585
Vanguard Russell 2000 ETF
VTWO
$17.3B
$1K ﹤0.01%
15
WKHS icon
586
Workhorse Group
WKHS
$33.2M
0
XYZ
587
Block Inc
XYZ
$48.4B
$1K ﹤0.01%
21
NAGE
588
Niagen Bioscience
NAGE
$271M
$1K ﹤0.01%
667
WTER
589
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
$1K ﹤0.01%
389
+1
+0.3% +$2
SRNE
590
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$1K ﹤0.01%
3,135
ETFC
591
DELISTED
E*Trade Financial Corporation
ETFC
$1K ﹤0.01%
115
ACIW icon
592
ACI Worldwide
ACIW
$5.83B
$0 ﹤0.01%
20
ATAI icon
593
AtaiBeckley Inc
ATAI
$2.66B
$0 ﹤0.01%
200
BAB icon
594
Invesco Taxable Municipal Bond ETF
BAB
$1.02B
-190
Closed -$5K
BB icon
595
BlackBerry
BB
$4.98B
-46
Closed
BOIL icon
596
ProShares Ultra Bloomberg Natural Gas
BOIL
$344M
0
CENN icon
597
Cenntro
CENN
$7.89M
$0 ﹤0.01%
1
CGC
598
Canopy Growth
CGC
$387M
$0 ﹤0.01%
4
CNXC icon
599
Concentrix
CNXC
$1.5B
$0 ﹤0.01%
5
COKE icon
600
Coca-Cola Consolidated
COKE
$12.5B
-320
Closed -$17K

Similar funds

AlphaMark Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, AlphaMark Advisors held 671 positions worth $217M, down 2.6% from $223M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

AlphaMark Advisors withdrew a net $14.7M in Q2 2023, closing 34 positions and reducing 179 holdings. Its most notable exit was Edwards Lifesciences, an estimated $2.23M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 6.3% a quarter earlier, followed by Consumer Staples and Healthcare.

Against the trend, AlphaMark Advisors opened a new position in Albemarle worth $530K.

  • AlphaMark Advisors's largest Q2 2023 buy was Albemarle: 2,377 shares worth $530K.
  • AlphaMark Advisors added most to Janus Henderson AAA CLO ETF in Q2 2023, an estimated $1.42M increase.
  • AlphaMark Advisors's biggest Q2 2023 reduction was State Street Technology Select Sector SPDR ETF, cutting an estimated $1.96M.
  • AlphaMark Advisors fully exited Edwards Lifesciences in Q2 2023, selling an estimated $2.23M.
  • AlphaMark Advisors's ten largest holdings make up 44% of its $217M portfolio in Q2 2023.
  • AlphaMark Advisors opened 37 new positions and closed 34 in Q2 2023.
  • AlphaMark Advisors's portfolio value fell 2.6% quarter-over-quarter to $217M.

Based on AlphaMark Advisors's 13F filing for Q2 2023, filed 28 Jul 2023.